Please assess the completion status of the following clinical trial:

Trial Title: Use of a Novel Fibrin Sealant in Total Knee Arthroplasty

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients must be male or female of any race~* Ages 18-80 years old~* Patients must be undergoing an elective, primary knee arthroplasty performed by the principal investigator~Exclusion Criteria:~* Allergy or intolerance to the study materials~* Surgical intervention during the past month for the treatment of the painful joint or its underlying etiology~* History of previous surgeries on the affected joint including previous arthroscopy (open surgeries)~* Women that are pregnant or may become pregnant~* Patient declines to participate

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: t

Study Arms:
- Control Group (Type: NO_INTERVENTION): Control group. Will not receive the fibrin spray.
- Treatment Group--Evicel Fibrin Spray (Type: ACTIVE_COMPARATOR): Patient will receive the fibrin spray after implantation of device but before the wound is closed.~Patients will be randomized to receive spray or not and postop parameters measured.

Based on this trial design, predict the completion outcome and termination type (if applicable).